HPAPIs- Smart monitoring and verification for containment strategies

09 October 2018
By ChargePoint Technology

The industry is currently seeing a sharp increase in demand for high potency active pharmaceutical ingredients (HPAPIs). This means that many manufacturers are considering which containment strategies will work well for them and meet their high potency handling requirements.

In his latest article for EPM Magazine, our global product manager Michael Avraam highlights the evolution of containment strategies, and analyses the role of containment verification and monitoring. Read the article in full here. 

Leave a Comment

Name
Email
Comment